Gilead Sciences Inc.

A bottle containing the drug Remdesivir is shown by a health worker at the Institute of Infectology of Kenezy Gyula Teaching Hospital of the University of Debrecen in Debrecen, Hungary, October 15, 2020. (Zsolt Czegledi/MTI via AP)

November 20, 2020, 1:44 pm

WHO advises against using drug remdesivir for treating COVID patients

UN organization claims the medicine, which has received approval as a coronavirus treatment from several health agencies, has ‘no important effect’ on improving survival chances

By Patrick Galey

Rubber stoppers are placed onto filled vials of the drug remdesivir at a Gilead manufacturing site in the United States, March 2020. (Gilead Sciences via AP)

October 23, 2020, 6:46 am

FDA approves first COVID-19 drug: antiviral remdesivir

Medicine found to cut recovery time by five days on average, but no studies have shown it improves chances of surviving the coronavirus

By MARILYNN MARCHIONE

Rubber stoppers are placed onto filled vials of the remdesivir at a Gilead manufacturing site in the US, in March 2020. (Gilead Sciences via AP)

June 16, 2020, 8:05 pm

Israel to accept COVID-19 drug remdesivir from US company

Government backs Health Ministry in authorizing Gilead Sciences’ donation of medicine

By TOI staff and Agencies

A vial of the drug remdesivir is viewed during a press conference about the start of a study with the drug in particularly severely ill patients at the University Hospital Eppendorf (UKE) in Hamburg, northern Germany, April 8, 2020, amidst the coronavirus pandemic. (Ulrich Perrey / POOL / AFP)

June 1, 2020, 8:24 pm

Gilead stock drops amid mixed results on drug remdesivir’s effects on virus

Company-led study finds those who who got medication for 5 days improved 65%, while there was no proven difference when getting it for 10 days; more details to be published

By AP and TOI staff

In this on May 19, 2020 file photo, a chemist holds a pack of hydroxychloroquine tablets in Mumbai, India. (AP/Rafiq Maqbool)

May 23, 2020, 5:01 pm

Big study casts more doubt on malaria drugs pushed by Trump as virus treatment

Researchers estimate death rate slightly higher among those taking hydroxychloroquine; separate study on remdesivir suggests benefit in treating COVID-19

By AP and TOI staff

Illustrative: A cybersecurity expert stands in front of a map of Iran as he speaks to journalists about the techniques of Iranian hacking, September 20, 2017, in Dubai, United Arab Emirates. (AP/Kamran Jebreili)

May 9, 2020, 4:24 am

Israeli firm uncovers Iran-linked attempt to hack US virus drugmaker Gilead

Pharmaceutical company is pioneering treatment for coronavirus; ClearSky cybersecurity outfit says Iran-connected hackers are targeting COVID-19 researchers, including in Israel

By TOI staff

May 4, 2020, 1:31 pm

Remdesivir results for virus encouraging but too early to celebrate — local CEO

FDA last week gave emergency approval to medicine produced by Gilead Sciences; it is believed to shorten illness time in some, but effect on mortality rates still unclear

By TOI staff and AP

Illustrative: Blood samples (AP Photo/Martin Mejia)

May 2, 2020, 4:47 pm

New US test could detect virus before patients become infectious

Defense Department working on new blood-based screening that identifies body’s immune response, may find illness 4 days earlier than current swab tests

By TOI staff and AP

May 2, 2020, 12:58 am

Trump announces emergency approval for 1st drug shown to help virus recovery

In preliminary US trial, Gilead Science’s remdesivir shortens recovery time by 4 days; cleared for use for hospitalized patients with ‘severe disease’

By MATTHEW PERRONE and MARILYNN MARCHIONE

A vial of Gilead Sciences' remdesivir drug is seen during a press conference about the start of a study with drug in particularly ill coronavirus patients at the University Hospital Eppendorf (UKE) in Hamburg, northern Germany on April 8, 2020. (Ulrich Perrey/Pool/AFP)

April 29, 2020, 7:35 pm

Experimental drug declared by US as first effective treatment against COVID-19

Dr. Anthony Fauci says trial on patients shows GIlead Sciences remdesivir ‘can block this virus,’ American government to work to boost availability of the antiviral medication

By Martin Crutsinger, MARILYNN MARCHIONE and Anne D'Innocenzio

Johnny, the bus driver from East Jerusalem who recovered from the coronavirus, is released from hospital, photo undated. (Maya Tzaben/Baruch Padeh Medical Center)

March 30, 2020, 8:37 pm

Bus driver who was Israel’s first serious virus patient makes full recovery

Johnny, from East Jerusalem, drove a group of Greek tourists later found to be carrying coronavirus; was treated with Remdesivir, which was originally developed for Ebola

By TOI staff

From the WebDecember 10, 2017, 2:07 pm

Gilead Sciences acquires CDL for $567m

Globes: Cell Design Labs (CDL) is developing cancer therapies based on CAR T, likely to be the next generation of medications

Kite Pharma develops cell therapies in which the patient's own immune cells fight cancer. (YouTube screenshot)

October 19, 2017, 3:49 pm

Israeli-founded Kite Pharma gets FDA nod for cancer therapy

Firm started by Israeli-US oncologist Arie Belldegrun was acquired by US firm Gilead Sciences for almost $12 billion in August

By Shoshanna Solomon

Weizmann Institute's Prof. Zelig Eshhar holds a board that illustrates how the cancer treatment works with mice. Aug. 29, 2017 (Shoshanna Solomon/Times of Israel)

August 30, 2017, 4:20 pm

Breakthrough Israeli cancer professor on prowl to ease other ills

Weizmann Institute’s Zelig Eshhar’s genetically engineered T-cells are at the heart of Kite Pharma’s $12 billion acquisition

By Shoshanna Solomon

Israeli-American oncologist Arie Belldegrun, founder of Kite Pharma. (YouTube screenshot)

August 28, 2017, 6:55 pm

Gilead to buy Israeli-founded Kite Pharma for nearly $12 billion

The US firm, founded in 2009 by Israeli-US oncologist Arie Belldegrun, develops cell therapies for cancer treatments

By Shoshanna Solomon